IL1RAP and chronic myelogenous leukemia, BCR-ABL1 positive: Secondly, they assessed the efficacy of IL1RAP CAR-T in vivo in two CML models (xenograft of KU812 or K562 cells) in comparison to untreated and Mock-T-treated mice (mice treated with Mock-T cells instead of CAR-T cells).